Eurobio Scientific Stock price

Equities

ALERS

FR0013240934

Biotechnology & Medical Research

Market Closed - Euronext Paris 12:35:26 2024-03-28 pm EDT 5-day change 1st Jan Change
16.1 EUR 0.00% Intraday chart for Eurobio Scientific +1.39% -2.19%
Sales 2023 * 130M 140M Sales 2024 * 138M 149M Capitalization 165M 178M
Net income 2023 * 10M 10.79M Net income 2024 * 12M 12.94M EV / Sales 2023 * 1.44 x
Net Debt 2023 * 23M 24.81M Net Debt 2024 * 4.6M 4.96M EV / Sales 2024 * 1.23 x
P/E ratio 2023 *
17.9 x
P/E ratio 2024 *
13.8 x
Employees 304
Yield 2023 *
-
Yield 2024 *
-
Free-Float 59.14%
More Fundamentals * Assessed data
Dynamic Chart
1 week+1.39%
Current month-3.01%
1 month-2.54%
3 months-0.86%
6 months+10.27%
Current year-2.19%
More quotes
1 week
15.70
Extreme 15.7
16.20
1 month
15.70
Extreme 15.7
17.10
Current year
15.20
Extreme 15.2
18.10
1 year
12.20
Extreme 12.2
18.10
3 years
12.20
Extreme 12.2
29.76
5 years
3.08
Extreme 3.08
29.76
10 years
2.92
Extreme 2.92
29.76
More quotes
Managers TitleAgeSince
Chief Executive Officer - 17-06-18
Director of Finance/CFO 43 22-09-30
Chief Operating Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 17-06-18
Director/Board Member 68 09-11-03
Director/Board Member 67 17-06-14
More insiders
Date Price Change Volume
24-03-28 16.1 0.00% 3,344
24-03-27 16.1 +1.26% 2,708
24-03-26 15.9 -0.62% 4,540
24-03-25 16 +1.39% 6,393
24-03-22 15.78 -1.38% 2,602

Real-time Euronext Paris, March 28, 2024 at 12:35 pm EDT

More quotes
Eurobio Scientific is a key player in the field of specialty in vitro diagnostics. It is involved from research to manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, Eurobio Scientific has established its own distribution network and a portfolio of proprietary products in the molecular biology field. The group has approximately 286 employees, three production units based in the Paris region, in Germany and in the United States, and subsidiaries in Dorking in the United Kingdom, Sissach in Switzerland, Bünde in Germany and Utrecht in the Netherlands.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.1 EUR
Average target price
29 EUR
Spread / Average Target
+80.12%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Eurobio Scientific - Euronext Paris